Clinical trial
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
NCT00204698 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00204698 |
|---|---|
| Title | Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment |
| Official title | Identification of Molecular Markers of Inflammatory Mediators in Posterior Laryngitis Due to Laryngopharyngeal Reflux and Evolution With PPI Treatment |
| Lead sponsor | University of Utah, Other |
| Collaborators | PriCara, Unit of Ortho-McNeil, Inc. Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Laryngopharyngeal Reflux |
| Intervention type | Drug |
| Interventions | Aciphex |
| Enrollment | 24 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: